Also on

  • Recent Health Care Events and News

    • In 2016, Analysis Group’s Health Care practice was recognized as an industry leader at prominent international conferences in the U.S., Asia, and Europe.

      Analysis Group presented a workshop, moderated an issue panel, and exhibited 18 posters at the 21st Annual International Meeting of the International Society for Pharmoeconomics and Outcomes Research (ISPOR). Research contributors included Managing Principals Mei Sheng Duh, Patrick Lefebvre, Edward Tuttle, Alan White, and Eric Wu; Vice Presidents James Signorovitch, Francis Vekeman, Jipan Xie, and Mihran Yenikomshian; Managers Wendy Cheng, Lynn Huynh, Nick Li, Elyse Swallow, and Hongbo Yang; and Senior Economists François Laliberté and Marie-Hélène Lafeuille.

      Senior researchers gave three podium and four poster presentations at the International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), which brought together epidemiologists in the pharmaceutical, legal, and health insurance industries, as well as from academia. Research contributors included Managing Principals Mei Sheng Duh and Patrick Lefebvre; Vice President Francis Vekeman; Managers Wendy Cheng and Lynn Huynh; and Senior Economist François Laliberté.

      Three of the posters supported by Analysis Group research were awarded medals at the Academy of Managed Care Pharmacy (AMCP) Nexus conference. The research, covering cardiac resynchronization therapy, Type 2 diabetes, and multiple sclerosis, was led by Managing Principals Mei Sheng Duh, Patrick Lefebvre, and Eric Wu, and Vice President James Signorovitch.

      The Institute for Clinical and Economic Review (ICER), an independent nonprofit research organization, recently commissioned a report on the cost-effectiveness of treatments for moderate-to-severe plaque psoriasis. An Analysis Group team including Managing Principal Eric Wu, Manager Keith Betts, and Associate Junlong Li reviewed the preliminary results of ICER’s analysis, and identified and recommended a number of areas to improve. 

      Principal Howard G. Birnbaum and Managing Principal Paul E. Greenberg have edited Decision Making in a World of Comparative Effective Research, which is scheduled for publication by Springer in Spring 2017. The book provides a practical guide to decision makers in the life sciences industry who commission comparative effectiveness research (CER), including pharmaceutical, biologic, and device manufacturers, as well as both public and private payers.